K & A Rare Disease Insights

Additional Information

  

Your company has identified a new product idea in the area of Rare Diseases, but you are uncertain whether other companies have already products under Orphan drug designation or you are interested in a more in-depth analysis of the companies involved in the rare disease area or the successful products having achieved the orphan drug status. Our company has set-up a database that contains all products which received the orphan drug designation from the FDA since 1983. This database is updated with the newest information from FDA on a weekly basis to maintain the database up to date.

In addition, a second part of the database contains more in-depth background information about the individual diseases

image1